ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,466.66
      -0.05%
      US Tech 100
      19,150.00
      -0.13%
      Dow Jones
      39,129.15
      0.04%
      Brent Oil
      84.285
      0.12%
      Bitcoin
      60,751.72
      -1.71%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Oxford Biomedica Plc (OXB) Quote

      Oxford Biomedica Plc

      Oxford Biomedica Plc (OXB)

      LSE
      300.00
      0.00
      (0.00%)
      Closed June 26 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      300.00
      Bid
      298.00
      Ask
      301.00
      Volume
      154,576
      297.00 Day's Range 306.50
      164.40 52 Week Range 460.00
      Market Cap
      299.542M
      Previous Close
      300.00
      Open
      306.00
      Last Trade
      32733
      @
      300
      (UT)
      Last Trade Time
      Financial Volume
      464,165p
      VWAP
      300.2826
      Average Volume (3m)
      268,646
      Shares Outstanding
      100,013,988
      Dividend Yield
      -
      PE Ratio
      -1.63
      Earnings Per Share (EPS)
      -1.84
      Revenue
      89.54M
      Net Profit
      -184.16M

      About Oxford Biomedica Plc

      Sector
      Medicinal Chems,botanicl Pds
      Industry
      Medicinal Chems,botanicl Pds
      Website
      www.oxb.com
      Headquarters
      Oxford, Gbr
      Founded
      1970
      Oxford Biomedica Plc is listed in the Medicinal Chems,botanicl Pds sector of the London Stock Exchange with ticker OXB. The last closing price for Oxford Biomedica was 300p. Over the last year, Oxford Biomedica shares have traded in a share price range of 164.40p to 460.00p.

      Oxford Biomedica currently has 100,013,988 shares outstanding. The market capitalization of Oxford Biomedica is £299.54 million. Oxford Biomedica has a price to earnings ratio (PE ratio) of -1.63.

      OXB Latest News

      More News

      FeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program

      5 hours ago

      Oxford Biomedica PLC Result of Annual General Meeting

      Oxford Biomedica PLC 24 June 2024         Oxford Biomedica Result of Annual General Meeting   Oxford, UK - 24 June 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or "the Company"), a...

      June 24 2024
      RNS Regulatory News

      Oxford Biomedica PLC Holding(s) in Company

      Oxford Biomedica PLC 21 June 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name OXFORD BIOMEDICA PLC UK or Non-UK Issuer UK 2...

      June 21 2024
      RNS Regulatory News

      Oxford Biomedica PLC Holding(s) in Company

      Oxford Biomedica PLC 20 June 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name OXFORD BIOMEDICA PLC UK or Non-UK Issuer UK 2...

      June 20 2024
      RNS Regulatory News

      Oxford Biomedica PLC Holding(s) in Company

      Oxford Biomedica PLC 20 June 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name OXFORD BIOMEDICA PLC UK or Non-UK Issuer UK 2...

      June 20 2024
      RNS Regulatory News

      Oxford Biomedica PLC Holding(s) in Company

      Oxford Biomedica PLC 20 June 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name OXFORD BIOMEDICA PLC UK or Non-UK Issuer UK 2...

      June 20 2024
      RNS Regulatory News

      Oxford Biomedica PLC Admission of Shares and Total Voting Rights

      Oxford Biomedica PLC 19 June 2024         Oxford Biomedica Admission of Shares and Total Voting Rights     Oxford, UK - 19 June 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or "the...

      June 19 2024
      RNS Regulatory News

      EARNINGS AND TRADING: Cordel thrilled by Middle East contract win

      The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...

      June 18 2024
      Alliance News

      Oxford Biomedica PLC Subscription of shares by Institut Mérieux

      Oxford Biomedica PLC 18 June 2024         Subscription of shares by Institut Mérieux Oxford, UK - 18 June 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica", "OXB" or "the Company"), a...

      June 18 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-25-7.69230769231325325296.590460308.55940389DE
      4-27-8.25688073394327343.5296.5135891320.70416493DE
      12103.852.9051987768196.2351188268646277.00829027DE
      26103.852.9051987768196.2351167262308229.48465083DE
      52-130-30.2325581395430460164.4258289237.4832519DE
      156-1000-76.923076923113001678164.4189315526.94532695DE
      260-408-57.62711864417081678164.4172248628.1147339DE

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WENAANEW MEDICAL INC
      $ 3.5601
      (115.76%)
      		84.16M
      CMAXCareMax Inc
      $ 3.6498
      (92.09%)
      		11.71M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.4365
      (64.72%)
      		594M
      OPTXSyntec Optics Holdings Inc
      $ 3.85
      (63.83%)
      		34.24M
      MEDSTRxADE HEALTH Inc
      $ 11.86
      (35.23%)
      		328.21k
      GRIGRI Bio Inc
      $ 1.8325
      (-38.30%)
      		671.03k
      BJDXBluejay Diagnostics Inc
      $ 1.72
      (-37.45%)
      		2.18M
      CNSPCNS Pharmaceuticals Inc
      $ 1.84
      (-35.21%)
      		1.39M
      LYELLyell Immunopharma Inc
      $ 1.325
      (-35.05%)
      		10.23M
      NUWENewellis Inc
      $ 0.142896
      (-34.39%)
      		10.55M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.4365
      (64.72%)
      		594M
      NVDANVIDIA Corporation
      $ 123.1494
      (-2.33%)
      		277.04M
      RIVNRivian Automotive Inc
      $ 14.23
      (18.98%)
      		226.94M
      SQQQProShares UltraPro Short QQQ
      $ 8.26
      (-1.55%)
      		89.62M
      WENAANEW MEDICAL INC
      $ 3.5601
      (115.76%)
      		84.16M

      Discussion

      View Full Feed
      tapioca tapioca 2 minutes ago
      Won’t even reach 100k vol today.
      RNAZ
      tw0122 tw0122 2 minutes ago
      CMAX 1.91 to 4.11 good one for sure but WENA OPTT OPTX FFIE also good days earlier on
      CMAX FFIE OPTT
      Biggiee Biggiee 2 minutes ago
      Looks like accumulation pattern today, won’t let her run past $7 just yet $EBS
      EBS
      WARHAMMER WARHAMMER 2 minutes ago
      I’m looking at VINE. But will wait until all who are selling bring it back to support. As they always do. Good alert!
      2can$ 2can$ 2 minutes ago
      New investors look at Jetmek ,Barber , and Idiot Mayor working hard today attacking positive post, factual post and anything that has to do with the illegal naked short in DBMM, what they attack is the very thing that is happening in DBMM.

      Very obvious what there agenda is, now they s
      DBMM
      Birdbrain Ideas Birdbrain Ideas 3 minutes ago
      Nah. The only company Amarin could settle with is Hikma. The other generics have not been sued. And they are Hikma's competitors. So the other generics are probably poised to benefit now that the lawsuit is reinstated against Hikma. They're probably hopeful that Hikma will be less interested in sell
      AMRN
      vlispxpert vlispxpert 3 minutes ago
      VINE we got time for dip, not happening for few weeks...daytraders will fade out & sell if it ain't jumping...attention span of gnats...

      Me? I'm holding post merger, the real action comes later..imo
      ducci1 ducci1 3 minutes ago
      Now Bouncing off Da Pivot 5462 !
      SPY
      CaptHowdy CaptHowdy 3 minutes ago
      RXMD's organic growth took nearly a decade of hard work, perseverance and top-notch professionalism for Ms. Mars & Armen to achieve the $40m market cap before current CEO screwed shareholders.

      It took "Fernandez the Flop" only 18 months to reduce that by 75%. Such a disgrace, this C
      RXMD
      srinsocal srinsocal 3 minutes ago
      Yep TP, this attention from new 'BIEL Experts' has frequently been followed by news in the past.
      BIEL
      dukeb dukeb 3 minutes ago
      Yeah, but why waste money on silly things like rent when that money can go into your pocket instead?

      I also think that Mark is cunning enough to dig into his pocket to pay the auditors. If he can get the financials out then he can proceed with the RS, issue billions more shares and k
      ZRFY
      The Night Stalker The Night Stalker 3 minutes ago
      5 year chart
      https://www.stockscores.com/charts/charts/?ticker=dpui
      DPUI
      SoxFan SoxFan 3 minutes ago
      I disagree. Sure you will be better if you add and your chances improve but either way I don’t see the Red Sox winning it all this season. In the long run you will be better off getting something for an asset than nothing. They could still make it in as a wild card.
      capgain capgain 3 minutes ago
      Sure can. Man, that was some good stuff a little before my time, but we still listened to their music in the 70's!
      train21 train21 3 minutes ago
      LIME IS WAITING FOR THE 0001s
      THATS THEIR PLAY BASH EVERY DAY THEN BUY AT 0001 AND THEN BE QUIET TILL THEY SELL OUT FOR A FEW TICKS AND THEN BASH AGAIN ???
      SFLM
      Money Management Money Management 3 minutes ago
      I predicted tomorrow morning it opens lower and close back higher
      RSPI
      arizona1 arizona1 3 minutes ago
      https://x.com/BidensWins/status/1805735122789957733
      SweetBlackCrude SweetBlackCrude 4 minutes ago
      There is a little thing called Operating Capital you need to run a business....and how do you buy a business that supposedly does $3M in Revs when you have NO MONEY???
      And the company happens to be GROSSLY OVERVALUED....love the clowns calling for cooper and silver....

      The comp
      GTVH
      RIOgrande44 RIOgrande44 4 minutes ago
      Does anyone know what the float is here?
      FOXO
      tw0122 tw0122 4 minutes ago
      CMAX 1.91 to 4.11 hod ROMA SGLY VINE
      CMAX
      Backstabbed Backstabbed 4 minutes ago
      ok that was funny :-)
      ASTA
      AlaskaOTC AlaskaOTC 4 minutes ago
      Looks like all the buyers are scared to take out that askhole VDOg
      VXIT
      Quintessence Quintessence 4 minutes ago
      Watching CMAXW and OPTXW. Both making moves today.
      Nvragn4 Nvragn4 4 minutes ago
      Large trade at .25
      SEQP

      Your Recent History

      LSE
      OXB
      Oxford Biomedica
      LSE
      AS71
      Comw.bk.a.24
      TSXV
      NIK
      Nikos Explorations Ltd.
      Delayed Upgrade Clock